Selvom dette ikke er dokumenteret for Irbesartan Winthrop, kan der forventes en lignende effekt med angiotensin- II - receptorantagonister.
While this is not documented with Irbesartan Winthrop, a similar effect should be anticipated with angiotensin-II receptor antagonists.